{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T09:06:30Z","timestamp":1750669590719,"version":"3.41.0"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anticancer Res"],"accepted":{"date-parts":[[2022,3,23]]},"published-print":{"date-parts":[[2022,5]]},"DOI":"10.21873\/anticanres.15745","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T10:45:19Z","timestamp":1652179519000},"page":"2675-2681","source":"Crossref","is-referenced-by-count":2,"title":["Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen"],"prefix":"10.21873","volume":"42","author":[{"given":"HIROAKI","family":"TANIOKA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEN","family":"SHIMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIHITO","family":"TSUJI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MITSUGU","family":"KOCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HO MIN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKAO","family":"TAKAHASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TADAMICHI","family":"DENDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKINORI","family":"TAKAGANE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKANORI","family":"WATANABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHITO","family":"KOTAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASATO","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YU","family":"SUNAKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHIRO","family":"TAKEUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WATARU","family":"ICHIKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASASHI","family":"FUJII","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"9336","published-online":{"date-parts":[[2022,4,30]]},"container-title":["Anticancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.21873\/anticanres.15745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:31:30Z","timestamp":1733142690000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/lookup\/doi\/10.21873\/anticanres.15745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,30]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,4,30]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.21873\/anticanres.15745"],"URL":"https:\/\/doi.org\/10.21873\/anticanres.15745","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"type":"print","value":"0250-7005"},{"type":"electronic","value":"1791-7530"}],"subject":[],"published":{"date-parts":[[2022,4,30]]}}}